This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Sarah Snykers
QC Manager at Celyad, Belgium


Sarah has over 10 years of experience in cell therapy, biomedical research and development.

She is a pharmacist from education and has a PhD in pharmaceutical and biomedical sciences, specialised in stem cell biology. In 2010, she joined Promethera BioSciences, a biopharmaceutical company dedicated to the development of cell therapy products based on allogeneic adult stem cell technology to treat liver diseases. She headed the R&D, QC and Preclinical Departments. In 2015, she joined Celyad, a biopharmaceutical company, specialised in autologous and allogeneic cell therapy. Celyad’s core business lies in the field of immune-oncology, and more specifically the development of NK-receptor based CAR T therapies. Sarah initially led the immune-oncology program at R&D level, focused on technology transfer, product characterization and optimization. Since 2016, she heads the QC Department, covering release of clinical products and raw material, analytical method development and translational research activities.